GLD Announces Successful Closing of Seelos Assets; Includes Ketamine and Trehalose Programs Advancing into Phase 3 Clinical Trials.
The post Seelos Therapeutics, Inc. Assets, Acquired through Bankruptcy appeared first on MedTech Intelligence.
Converting promising technologies into durable outcomes, experience, and cost at scale with evolving technologies and disruptive innovation.
The post Disruptive Innovation in MedTech: Evolving Characteristics and Modern Realities appeared first on MedTech Intelligence.
Seek partners who can see your vision — the full picture, anticipate challenges, and help you navigate complexity with confidence.
The post Product Development Outsourcing Needs Speed, Safety & Certainty appeared first on MedTech Intelligence.
Sunrise Labs rebrands as Suntra Medtech Solutions with a strategic repositioning to meet the demands of a rapidly transforming healthcare industry where speed, precision, and integrated thinking are more essential than ever.
The post Sunrise Labs Rebrands as Suntra MedTech Solutions™ appeared first on MedTech Intelligence.
Notified bodies receive numerous questions from legal manufacturers during technical assessments. We cannot always answer them for individual legal manufacturers because this would constitute consultation.
The post 4 FAQs to Notified Bodies appeared first on MedTech Intelligence.
To navigate increasingly complex global regulations and rising market expectations, organizations are embracing the Intelligent MedTech Lifecycle: a unified, data-driven approach that breaks down silos and drives agility across the entire product journey.
The post Managing MedTech Cost Pressures With Data-Driven Lifecycle Intelligence appeared first on MedTech Intelligence.
Innovation, implementation & utilization of medical technology
